Crossmark

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol

Crossref DOI link: https://doi.org/10.1186/s12944-020-01292-w

Published Online: 2020-06-06

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fonseca, Liliana https://orcid.org/0000-0002-3318-8308
Paredes, Sílvia

Ramos, Helena

Oliveira, José Carlos

Palma, Isabel
License Information

Text and Data Mining valid from 2020-06-06

Version of Record valid from 2020-06-06
More Information

Article History

Received: 8 February 2020

Accepted: 20 May 2020

First Online: 6 June 2020

Ethics approval and consent to participate

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the local Ethics committee (150-DEFI/149-CES). Due to the retrospective nature of this study, consent to participate was waived by the Ethics Committee.

: Liliana Fonseca assigns Lipids in Health and Disease all rights of copyright.

: The authors declare that they have no competing interests.Liliana Fonseca declares that she has no conflict of interest. Silvia Paredes declares that she has no conflict of interest. Helena Ramos declares that she has no conflict of interest. José Carlos Oliveira declares that he has no conflict of interest. Isabel Palma declares that she has no conflict of interest.

Document is current

Any future updates will be listed below